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Original Article
Ethnic Disparities in Cervical Cancer Survival
Among Texas Women
Ann L. Coker, Ph.D.,1 Christopher P. DeSimone, M.D.,2 Katherine S. Eggleston, MSPH,3
Arica L. White, M.P.H.,3 and Melanie Williams, Ph.D.4
Abstract
Objective: The aim of thisworkwas to determinewhetherminoritywomen aremore likely to die of cervical cancer.
A population-based cohort study was performed using Texas Cancer Registry (TCR) data from 1998 to 2002.
Methods: A total of 5,166 women with cervical cancer were identified during 1998–2002 through the TCR.
Measures of socioeconomic status (SES) and urbanization were created using census block group-level data.
Multilevel logistic regression was used to calculate the odds of dying from cervical cancer by race, and Cox
proportional hazards modeling was used for cervical cancer-specific survival analysis.
Results: After adjusting for age, SES, urbanization, stage, cell type, and treatment, Hispanic women were
significantly less likely than non-Hispanic White women to die from cervical cancer (adjusted hazard ratio
[aHR]¼ 0.69; 95% CI [confidence interval]¼ 0.59–0.80), whereas Black women were more likely to die
(aHR¼ 1.26; 95% CI¼ 1.06–1.50). Black and Hispanic women were more likely to be diagnosed at a later stage
than White women. Black women were significantly less likely to receive surgery among those diagnosed with
localized disease ( p¼ 0.001) relative to both White and Hispanic women.
Conclusions: Relative to non-Hispanic White women, Black women were more likely to die of cervical cancer
while Hispanic women were less likely to die; these survival differences were not explained by SES, urbani-
zation, age, cell type, stage at diagnosis, or treatment.
Introduction
Reasons for racial=ethnic disparities in cervical sur-vival have yet to be determined. Factors, including socio-
economic status (SES), urbanization, stage at diagnosis, and
treatment received, may explain decreased survival among
Black women. Of studies addressing SES and cervical cancer
survival,1–10 approximately one-third found that the associa-
tion between low SES and poorer survival persisted after
controlling for race=ethnicity.3,7,11 In our prior analysis, we
observed that women living in neighborhoods of lower SES
were less likely to survive from cervical cancer, yet Hispanic
women had a pronounced survival advantage.2 We hypoth-
esized that differences in treatment received may influence
these observed survival differences.
This report expands on the earlier study2 using newly
available treatment data obtained from the Texas Cancer
Registry (TCR), as well as more precise census block group-
level data to define SES. The purpose of this population-based
cohort study was to determine whether women of minority
race remained at greater risk of dying from cervical cancer
after considering demographic attributes, treatment received,
cell type, and stage at diagnosis.
Methods
Cervical cancer cases were obtained from the TCR, a
population-based registry of all cancer cases diagnosed in
Texas. These data met Centers for Disease Control and Pre-
vention’s National Program of Cancer Registries (NPCR) and
North American Association of Central Cancer Registries
(NAACCR) national cancer incidence data standards, and
had a case completeness proportion of 99%.12 Institutional
Review Boards from the Texas Department of State Health
Services and the University of Texas Health Science Center at
Houston approved the study protocol. All datawere analyzed
1Department of Obstetrics and Gynecology, Center for Research on Violence Against Women, University of Kentucky, Lexington,
Kentucky.
2Department of Obstetrics and Gynecology, University of Kentucky, Lexington, Kentucky.
3School of Public Health, University of Texas Health Science Center, Houston, Texas.
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using the statistical software package Intercooled Stata ver-
sion 9.2. Incident cases from 1998–2002 were linked with the
Texas Department of State Health Services mortality data
through December 31, 2003 to identify vital status, date of
death, and underlying causes of death. The study population
includedwomen 18 years or older diagnosedwith an invasive
primary cervical cancer (ICD-0-3 codes C53.0, C53.1, C53.8,
and C53.9; excluding the following histology codes: 9590–
9989, 9050–9055, and 9140).
Socioeconomic status, urbanization, and race
Individual data to characterize SES is not collected by the
TCR; thus, block group-level data (U.S. Census from 2000)
was used to create a composite variable for SES based on an
accepted measure of community-level SES.13–15 Briefly, in-
dividual items from the census included in this measure
were: median household income, proportion below pov-
erty, proportion with a college education, proportion with a
management=professional occupation, and median home
value. Principal factor analysis with varimax rotation was
utilized to retain one factor representing a composite SES.
Analysis of the individual components of the composite var-
iable showed good internal consistency (Cronbach’s alpha¼
0.87). SES was then categorized into quintiles based on the
distribution among Texas residents. Data was geocoded by
batch method using Atlas, version 4.0. Addresses that did not
match were manually geocoded by relaxing attributes such as
zip code and street (13% of all cases); by relaxing the re-
quirement of matching all attributes, the probability of find-
ing a match is improved. These addresses were not assigned
to the center of the zip code, but used the remaining attributes
of the address to code the data. Remaining cases were as-
signed to the block group of a randomly matched case iden-
tical to their zip code, race, age, and sex (16.5% of all cases).
Urbanization was defined using Rural Urban Commuting
Area Codes (RUCA) available at the census track level.16 The
following categories were used: urban, large town, small
town, and isolated town.
Race=ethnicity was abstracted from medical records by
cancer registrars and categorized as non-Hispanic White,
hereafter White (referent group); non-Hispanic Black, here-
after Black; and Hispanic. We did not have data to define race
within the Hispanic grouping; however, in Texas, the over-
whelming majority of Hispanic women are White and from
Mexico or Central America.
Cancer stage
Data characterizing stage at diagnoses were obtained from
the TCR and reported using the Surveillance, Epidemiology
and End Results (SEER) summary staging guide.
Treatment
First course of treatment received was available from the
TCR. Receipt of any treatment was first defined as a dichot-
omous variable: received any type of treatment or received no
treatment. Treatments were then classified by the combina-
tion of all types received: surgery alone; surgery and che-
motherapy or radiation; and chemotherapy or radiation
alone. The type of surgery was also available and was cate-
gorized as follows: (1) leep, laser, or cone, (2) radical hyster-
ectomy, (3) total abdominal or vaginal hysterectomy, (4)
exenteration, and (5) surgery of unknown type. For the pur-
poses of this model, we assumed that those missing for the
treatment did not receive the treatment.
Cervical cancer survival
Survival wasmeasured inmonths fromdate of diagnosis to
date of follow-up; 5,454 women were reported to the TCR
with cervical cancer during 1998–2002. Vital status was de-
termined through 2003 to allow for at least 1 year of follow-up
(range, 1–6 years). Women were excluded from analyses for
the following reasons: (1) unknown race=ethnicity (n¼ 169),
(2) diagnosed by death certificate only (n¼ 111), and (3) no
corresponding census data (n¼ 8). A total of 5,166 were
available for final analysis. Additionally, women who died
from causes other than cervical cancer (n¼ 436) were ex-
cluded from cause-specific survival analysis. The racial=
ethnic distribution of women excluded from survival analysis
did not differ from the full sample. Potential confounders
included age, stage, and cancer cell type (grouped as squa-
mous and non-squamous). The majority of cervical cancer is
squamous cell in origin. Non-squamous cervical cancer is
primarily adenocarcinoma and may have a lower survival
rate than squamous cell cancer of the cervix.17
Statistical analysis
Using Stata version 9.2, the Generalized Linear Latent and
Mixed Models (GLLAMM) program, was used to perform
multilevel analyses to determine correlates of (1) being diag-
nosed beyond localized disease and (2) dying from cervical
cancer. This hierarchical regression model was used to ac-
count for block group (community)-level measures of SES and
urbanization combined with individual-level data, including
race=ethnicity, age, cancer stage, cell type, vital status, and
treatment. Multinomial logistic regression, calculating odds
ratios (Ors), was used to investigate treatment differences
across race=ethnicity while adjusting for SES, urbanization,
age, cancer stage, and cell type.
A standard Kaplan-Meier approach was used in this sur-
vival analysis; survival curves are presented in Figure 1 by the
three race=ethnicity groups. Differences in the following list of
risk factors were investigated by race=ethnicity using multi-
variate modeling: SES, urbanization, age, stage, cell type,
stage, and treatment received (Table 1). Multivariate Cox
proportional hazards modeling was used to estimate the rel-
ative risk of dying from cervical cancer by race=ethnicity
while adjusting for the covariates listed above, dying from
other causes were censored (Table 2). Lastly, to examine the
effect of stage on the association between race=ethnicity and
survival, a parallel set of the Cox proportional hazard ana-
lyses to that presented in Table 1were replicated by stagewith
cervical cancer-specific survival as the outcome (Table 3).
Results
Race=ethnic differences by covariates
When compared with White women, both Black and His-
panic women were more likely to live in lower SES neigh-
borhoods and urban areas (Table 1). Black women were
significantly more likely to be diagnosed at a later age com-
pared with White or Hispanic women. Black and Hispanic
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FIG. 1. Kaplan-Meier curves for cervical cancer-specific survival by race.
Table 1. Multilevel Analysis of Stage at Diagnosis by Sociodemographic Characteristics
of 5,166 Cervical Cancer Cases Reported to the Texas Cancer Registry 1998–2002{
Non-Hispanic White Non-Hispanic Black Hispanic
All 2698 711 1757
SES
Highest SES 40.7% 16.5% 14.8%
Middle SES 34.6% 27.3% 26.4%
Lowest SES 24.7% 56.2% 58.8%
p for trend REF p< 0.0001 p< 0.0001
Urbanization
Urban 80.6% 86.9% 87.0%
Large town 10.4% 8.0% 9.0%
Small town=rural 9.0% 5.1% 4.0%
p for trend REF ( p< 0.0001) p< 0.0001
Age at diagnosis (mean) 49.71 (REF) 52.71 ( p< 0.0001) 49.01 ( p¼ 0.15)
Cell type
Squamous 74.1% 83.0% 81.4%
Non-squamous 25.9% 17.0% ( p< 0.0001) 18.6% ( p< 0.0001)
Stage of diagnosis
Localized 52.8% 43.2% 47.2%
Regional 25.0% 32.5% 30.3%
Distant 7.7% 9.1% 8.4%
Trend (excludes unknown stage) REF ( p¼ 0.009) ( p¼ 0.04)
Unknown 14.5% 15.2% 14.1%
Treatment
No treatment documented 10.86% 12.13% (0.44) 13.36% (0.48)
Missing treatment data 28.27% 29.96% (0.92) 29.16% (0.84)
Type of treatment
Surgery alone 40.57% 26.86% (0.003) 31.15% (0.004)
Surgeryþ chemo=radiation 19.19% 17.58% (0.32) 20.56% (0.43)
Chemo=radiation 29.38% 42.19% (0.002) 36.16% (0.11)
Among those with localized disease n¼ 1426 n¼ 307 n¼ 827
Surgery 77.98% 62.54% (0.001) 72.29% (0.21)
Among those diagnosed at regional=late
stage at diagnosis
n¼ 882 n¼ 296 n¼ 681
Surgeryþ chemo=radiation; or chemo=radiation 78.68% 81.08% (0.57) 80.03% (0.92)
{Adjusting for all variables in the table.
SES, socioeconomic status; REF, referent group.
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women were more likely than Whites to be diagnosed with
squamous cell cervical cancer. Black (56.8%) and Hispanic
women (52.9%) were more likely to be diagnosed with ad-
vanced disease (regional or distant stages) relative to White
women (47.2%). The adjusted odds ratio (aOR) for this asso-
ciation for Black relative to White women was 1.27 (95%
confidence interval [CI]¼ 1.06–1.52) and 1.16 (95% CI¼ 1.02–
1.33) for Hispanic relative to White women. ORs were ad-
justed for age, race=ethnicity, SES, urbanization, and cell type.
No statistically significant differences in the proportion of
women who did not receive treatment or the completeness of
medical records were noted across race=ethnicity. However,
Black (26.9%) and Hispanic women (31.2%) were less likely to
have received surgery alone compared with Whites (40.6%);
the corresponding aOR for Black women was 0.61 (95%
CI¼ 0.54–0.70) and 0.82 (95% CI¼ 0.76–0.88) for Hispanic
women. Black women were more likely to have received
radiation or chemotherapy yet no surgery when compared
with Whites (aOR¼ 1.55; 95% CI¼ 1.36–1.76). When re-
stricted to localized disease, where surgery is the optimal
treatment, Black women were significantly less likely to re-
ceive surgery compared to White women (aOR¼ 0.55; 95%
CI¼ 0.45–0.67.
Kaplan-Meier survival curves by race=ethnicity
As can be observed in Figure 1, the survival curve for Black
women is considerably lower than that for White or Hispanic
women. This figure does not adjust for covariates. For these
analyses, we turn to multivariate Cox.
Multivariate Cox analysis and multilevel GLLAMM
Black women were more likely to die of cervical cancer
(HR: 1.26; 95% CI¼ 1.06–1.50), while Hispanic women were
Table 2. Multivariate Predictors of Cervical Cancer-Specific Survival for Women Diagnosed
and Reported to the Texas Cancer Registry during 1998–2002 with Treatment Data
N* CxCa mortality rate{ Adjusted HR (95% CI){
All 4730 5.42
Race=ethnicity
Non-Hispanic White 2,458 5.16 1.00 (REF)
Non-Hispanic Black 636 8.44 1.26 (1.06–1.50)
Hispanic 1,636 4.70 0.69 (0.59–0.80)
SES
High SES 1,365 4.42 1.00 (REF)
Mid SES 1,462 5.65 1.11 (0.93–1.32)
Low SES 1,903 5.97 1.27 (1.07–1.51)
p for trend 0.005
Urbanization
Urban 3,971 5.28 1.00 (REF)
Large town 449 5.29 1.10 (0.88–1.37)
Small town=rural 310 7.11 1.27 (1.01–1.61)
p for trend 0.04
Age [continuous] 4,730 5.42 1.02 (1.01–1.02)
Cell type
Squamous 3,710 5.50 1.00 (REF)
Non-squamous 1020 5.11 0.99 (0.84–1.16)
Treatment
No treatment 508 10.08 1.59 (1.32–1.92)
Any treatment 4,222 4.95 1.00 (REF)
Type of treatment
Surgery 1,749 1.02 0.20 (0.13–0.30)
Surgeryþ chemo=radiation 926 6.02 0.63 (0.44–0.89)
Chemo=radiation 1548 10.63 0.85 (0.70–1.04)
Surgery by type 2675
Leep, laser, cone 536 4.08 0.75 (0.60–0.94)
Radical hysterectomy 798 1.77 0.39 (0.29–0.52)
Total abdominal or vaginal hysterectomy 1044 1.79 0.39 (0.30–0.50)
Exenteration 20 9.20 0.87 (0.41–1.84)
Surgery unknown type 256 4.19 0.51 (0.37–0.69)
Stage of diagnosis
Localized 2,560 1.87 1.00 (REF)
Regional 1,441 8.95 4.30 (3.62–5.12)
Distant 418 30.32 12.99 (10.65–15.85)
Trend (excludes unknown stage) p< 0.001
Unknown 747 6.03 2.53 (2.02–3.17)
*Women dying from causes other than cervical cancer (n¼ 436) were excluded from analysis.
{Mortality rate calculated per 1000 woman months.
{Adjusted for age (continuous), race, stage, cell type, SES, urbanization, and treatment.
CxCa, cervical cancer; HR, hazard ratio; CI, confidence interval; SES, socioeconomic status; REF, referent group.
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less likely to die of cervical cancer (HR: 0.69; 95% CI¼ 0.59–
0.80) when compared with White women and adjusting for
confounders (Table 3). A similar patternwas also observed for
the multilevel logistic analysis for cervical cancer-specific
mortality as well as all cause survival (data not presented).
Other demographic factors associated with shorter cervical
cancer-specific survival included lower SES, more rural resi-
dence, and increased age (Table 2). Not receiving treatment
was associated with a 59% increased risk of dying from cer-
vical cancer. Receipt of surgery alone was associated with a
significant increase in survival (HR: 0.20; 95% CI¼ 0.13–0.30;
Table 2). Similarly, receipt of surgery in combination with
chemotherapy and=or radiation increased survival by 37%.
As anticipated, advanced stage at diagnosis was associated
with reduced survival. With the exception of the association
with urbanization, all findings from survival analysis (Table
2) were supported in the multilevel logistic regression anal-
ysis (data not presented). Multivariate Cox analysis for cer-
vical cancer-specific survival by stage (localized, regional=
distant, and unknown stage; Table 3)
Analysis conducted by stage revealed that Black women
with an unknown stage at diagnosis were almost twice as
likely to die of cervical cancer ( p< 0.0001) relative to Whites.
A reduced risk of dying of cervical cancer for Hispanicwomen
relative toWhite women was observed, yet only among those
diagnosed at regional or distant stage (Table 3).
Not receiving treatment was strongly associated with re-
duced survival for those diagnosed with localized and
regional=distant disease. Receipt of surgery was associated
with increased survival at all stages, while chemotherapy and
radiation were associated with reduced survival for those
diagnosed with localized and regional=distant disease
(Table 3).
Discussion
The persistent survival advantage observed for Hispanic
women corroborates our earlier analysis which did not have
data to characterize treatment.2 However, treatment did not
explain survival differences between Hispanic and White
women.
It is puzzling that Hispanic women have better survival
than White women despite their lower SES. Reasons for
this ‘‘Hispanic paradox’’18–20 may include differences in co-
morbid conditions, social support, religion=faith, or other
cultural influences.
Table 3. Multivariate Predictors of Survival for Women Diagnosed with Cervical Cancer
and Reported to the Texas Cancer Registry during 1998–2002 with Treatment Data
by Stage for Cervical Cancer-Specific Mortality
Attribute
Localized stage,
adjusted HR (95% CI){
Regional=distant stage,
adjusted HR (95% CI){
Unknown stage,
adjusted HR (95% CI){
n¼ 4370* n¼ 2,441 n¼ 1,620 n¼ 669
Non-Hispanic White 1.00 (REF) 1.00 (REF) 1.00 (REF)
Non-Hispanic Black 1.19 (0.79–1.79) 1.16 (0.93–1.44) 1.83 (1.19–2.82)
Hispanic 0.83 (0.58–1.17) 0.66 (0.54–0.80) 0.95 (0.64–1.42)
Neighborhood SES
High SES 1.00 (REF) 1.00 (REF) 1.00 (REF)
Mid SES 1.52 (1.03–2.24) 0.99 (0.80–1.23) 1.13 (0.72–1.79)
Low SES 1.43 (0.96–2.13) 1.15 (0.93–1.42) 1.11 (0.72–1.73)
p for trend 0.10 0.15 0.67
Urbanization
Urban 1.00 (REF) 1.00 (REF) 1.00 (REF)
Large town 0.95 (0.59–1.54) 1.07 (0.81–1.41) 1.06 (0.64–1.75)
Small town=rural 1.00 (0.59–1.69) 1.31 (0.97–1.76) 1.59 (0.92–2.73)
p for trend 0.93 0.09 0.13
Age [continuous] 1.03 (1.02–1.04) 1.01 (1.00–1.02) 1.03 (1.02–1.04)
Cell type
Squamous 1.00 (REF) 1.00 (REF) 1.00 (REF)
Non-squamous 1.06 (0.76–1.48) 1.13 (0.93–1.37) 0.93 (0.60–1.44)
Treatment
Any treatment 1.00 (REF) 1.00 (REF) 1.00 (REF)
No treatment 4.56 (3.10–6.76) 1.94 (1.51–2.52) 1.17 (0.84–1.61)
Type of treatment
Surgery 0.07 (0.04–0.12) 0.24 (0.16–0.37) 0.22 (0.11–0.44)
Surgery þ chemo=radiation 0.27 (0.16–0.43) 0.44 (0.33–0.59) 1.12 (0.68–1.86)
Chemo=radiation 0.56 (0.37–0.85) 0.60 (0.46–0.78) 1.28 (0.90–1.82)
Surgery by type
Leep, laser, cone 0.40 (0.24–0.64) 1.03 (0.78–1.36) 0.51 (0.28–0.94)
Radical hysterectomy 0.21 (0.12–0.37) 0.39 (0.27–0.54) 0.29 (0.09–0.90)
Total abdominal or vaginal hysterectomy 0.20 (0.12–0.31) 0.46 (0.33–0.62) 0.50 (0.24–1.04)
Exenteration 1.04 (0.14–7.65) 0.74 (0.28–2.00) 2.05 (0.46–9.14)
Surgery unknown type 0.30 (0.12–0.76) 0.60 (0.42–0.85) 0.42 (0.17–1.04)
*Women dying from causes other than cervical cancer (n¼ 436) were excluded from analysis.
{Adjusted for age (continuous), race, stage, cell type, SES, urbanization, and treatment.
SES, socioeconomic status; HR, hazard ratio; CI, confidence interval; REF, referent group.
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While Hispanic women appear to have a cervical cancer
survival advantage relative to White women, Black women
were more likely to die of cervical cancer particularly if
stage at diagnosis was unknown. Among those diagnosed
with localized disease, Black women were significantly less
likely to have surgery, while Hispanic women were similar
to Whites in their receipt of surgery. These data suggest
that Black women may receive less optimal treatment and
are more likely to die of cervical cancer even among those
who receive treatment. Explanations for this disparity in
cervical cancer treatment and survival may include resid-
ual confounding by individual SES. However, Hispanic
women reside in similar if not lower SES neighborhoods
than do Black women yet Hispanic women have a survival
advantage. Hispanic women do have treatment rates that
are comparable to White women. Perhaps Hispanic
women have social networks that support their receipt of
health care at rates greater than that of White or Black
women.
Strengths and weaknesses of the study
The use of a population-based cancer registry that meets
national data quality standards and a high case completeness
rate (99%) is a strength for this study.12
The use of census block group-level data to characterize
SES is a strength as was the addition of treatment data.
Missing data is always a limitation of analyses based on ex-
isting records. Older women ( p¼ 0.001), those living in areas
of very low SES ( p¼ 0.01), those with no record of treatment
( p< 0.001), and women with squamous cell cervical cancer
( p¼ 0.001) were more likely to be missing stage information.
In these data, missing data to characterize stage at diagnosis is
likely not missing at random, and may be due to poor health
status of the patient due to comorbidities. Women with
missing treatment information were more likely to live in
areas of very low SES ( p¼ 0.008), large towns ( p¼ 0.007), and
be diagnosed in late stage ( p< 0.001) or be missing stage
( p< 0.001). We do not have information on comorbid condi-
tions or other important risk factors for cervical cancer
including cigarette smoking or education. However, neigh-
borhood SES is highly correlated with individual education
and smoking status.
We did not have information on insurance status for this
analysis. An estimated 43% of Texans under the age of 65
had no health insurance for all or part of 2002–2003, and mi-
nority women are overrepresented among the uninsured.21
Insurance status may explain some of the observed differ-
ences in Black relative to White women, but not between
Hispanic and Black women. Other investigators22 have pos-
ited that strong family and community ties, and willingness
to pool resources may explain better outcomes for Hispanic
women relative to White and Black women. While we did
evaluate rural residence as a proxy for transportation barri-
ers, we could not measure other social or cultural barriers
to care.
Suggested future research directions with surveillance data
include obtaining data at the individual level to better char-
acterize SES, perhaps through health insurance coverage.
Obtaining information on comorbid conditions as well as
smoking status would also be an important contribution to
better understanding the effect of race=ethnicity on cervical
cancer survival.
Further efforts are needed to better understand why Black
women in particular have lower survival from cervical cancer
and lower rates of treatment. Possible avenues to explore may
include communication barriers between patients and pro-
viders, limited insurance coverage, claims denials, competing
obligations such as caring for parents, children, and=or
grandchildren, and limited social support to negotiate health
care systems. Both qualitative and quantitative research may
be beneficial in understanding why Black women are more
likely than White women to die of cervical cancer.
Disclosure Statement
No competing financial interests exist.
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